MetaTOC stay on top of your field, easily

A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort

, , , , , , , , , , , , , , , , , , , ,

Therapeutic Advances in Medical Oncology

Published online on

Abstract

Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Anti-programmed death-1 (PD-1)/cytotoxic T lymphocyte antigen-4 antibodies are efficacious in various malignancies. The potential role of dual checkpoint inhibitors in many rare solid tumors is not established.Objectives:This study presents the ...